Held in conjunction with the Society’s 38th Annual Meeting & Pre-Conference Programs, the largest conference in the world dedicated to cancer immunotherapy, aspiring scientists and doctors can discover the field of cancer immunotherapy through networking with local mentors from various backgrounds and listening to two distinct career panels featuring diverse scientists and clinicians at various stages in their careers. Students will gain new perspectives of the different career pathways available in science and medicine.
“SITC is excited to host its second URG Undergraduate in STEM Program and bring the initiative to San Diego,” said Mary Dean, JD, CAE, SITC Executive Director. “It is always inspiring to meet with participants, and I look forward to introducing students from San Diego’s local colleges and universities to this exciting area of science and medicine.”
RSVPs are due Oct. 18. For more information and to reserve a spot, click here.
About SITC Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn, Facebook, Instagram and YouTube.
Media Contact
Thomas Martin, Society for Immunotherapy of Cancer, 414-271-2456, [email protected], sitcancer.org
“This partnership with Hunova is a testament to our commitment to staying at the forefront of AI recruitment technology in a way that improves the recruiter and candidate experience,” said Ben Mones, CEO and Founder of Fama. “By integrating psychological traits assessment through textual analysis of a person’s web presence, we’re truly pushing the boundaries. Together, we’re merging the science of psychology with the power of technology, setting the stage for a new era in talent acquisition that makes hiring not just more efficient but also more precise.”
Arthur Tisi, CEO of Hunova, said, “We’re focused on changing how people are understood for the better. Our approach combines expansive use of advanced AI with deep psychological analysis based on our strong team of psychologists headed by our Chief Psychology Officer, Dr. Harold Goldstein.” Dr. Goldstein, who also heads Hunova Labs, stated, “Our focus is on using this exciting new technology as a lens to more fully capture the rich array of competencies that human beings bring to an organization. Our methods use scientific rigor to ensure the validity of our measures while leveraging novel approaches for reducing bias so that our assessments are fair for a diverse workforce.”
Fama has helped over 2,500 companies screen over 45 million candidates for workplace misconduct to reduce risk to organizations. To learn more, visit Fama at HR Tech Booth #5641 for an exclusive preview of the capabilities poised to change the future of hiring.
About Fama Fama is the innovator in online screening that makes hiring great people easy. Combining Fama’s groundbreaking AI technology and ability to integrate across the HR Tech stack, the solution compliantly searches 10,000 online public sources to help companies avoid workplace misconduct, prevent costly legal action, and ultimately, make better decisions. By modernizing candidate screening and due diligence, Fama helps organizations, agencies, and investors improve the quality of hires, make the most of each investment, and build successful businesses.
Headquartered in Los Angeles, CA, Fama is FCRA, EEOC, and SOC2 compliant and integrates with major HRIS, ATS, and background check solutions. To learn more, visit http://www.fama.io.
About Hunova Hunova is an enterprise insights and solution technology built on a proprietary assessment framework that emphasizes validity and fairness. Hunova’s solution can rapidly yet impartially identify an individual’s distinct competencies and provide scalable insights toward professional development.
For further information or media inquiries, please contact: Aimee Eichelberger [email protected] 312-952-1528
Join this webinar to learn about cell-free riboswitches, their development using microfluid droplet sorting and their role in intercellular communication.
Join Yohei Yokobayashi, PhD, Professor, Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology, for the live webinar on Monday, October 16, 2023, at 1pm PDT (4pm EDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
“The medical community recognizes the importance of SDOH,” stated Greg Smith, Vice President of Services Delivery at Messaging Architects. “However, lack of standardization and other challenges make it difficult for these organizations to leverage this data to improve health outcomes.”
Social and Economic Factors Critical to Healthcare Success
“SDOH data can help healthcare organizations improve patient outcomes first by identifying the needs and challenges of different populations. Having identified specific needs and trends, providers can then develop interventions tailored to addressing root causes of health disparities. And by collaborating with other stakeholders, they can create important systemic changes.”
Challenges to Gathering and Using SDOH Data
“While the healthcare community largely agrees on the value of SDOH data, collecting and using that information effectively involves challenges. For instance, a lack of standardization in how and what data are collected reduces data value. As yet, no consensus exists on what constitutes SDOH and how to store, measure, and report the data.”
Best Practices for Collecting and Managing SDOH Data
“Overcoming these challenges will require more collaboration and innovation among stakeholders from multiple sectors. For example, organizations can use methods such as surveys, screening tools, and interviews to collect SDOH data. Using tools and methods that have been tested and standardized will help ensure the quality and usability of the data.”
“Because of the nature of the data collected, organizations must ensure regulatory compliance, preserving data security and privacy. In addition to informed consent, this may include anonymizing the data and implementing data encryption. It will also involve carefully managing data access and data lifecycle.”
Data Management Professionals
By collecting, integrating, and using SDOH data wisely, healthcare entities can design programs to effectively address health disparities. An important step in this process involves information governance, the process of locating, managing and securing data across the enterprise. The information governance experts at Messaging Architects help healthcare organizations harness the power of their data.
Messaging Architects specializes in effectively managing and securing an organization’s most precious asset, its information. With over 20 years of information management and technology consulting experience, the Messaging Architects team has provided corporations, educational intuitions, health care facilities and nonprofits with methodologies, procedures, and technology to keep their data organized, compliant and secure.
About eMazzanti Technologies
eMazzanti’s team of trained, certified IT experts rapidly deliver increased revenue growth, data security and productivity for clients ranging from law firms to high-end global retailers, expertly providing advanced business cyber security, retail and payment technology, digital marketing services, AI, cloud and mobile solutions, multi-site implementations, 24×7 outsourced network management, remote monitoring, and support.
eMazzanti’s consistent growth landed them on the Inc. 5000 list 9X. Recognized as a 4X Microsoft Partner of the Year, the #1 ranked NYC area MSP, NJ Business of the Year, and 5X WatchGuard Partner of the Year, the company excels as a trusted outsourced IT partner! Contact: 1-866-362-9926, [email protected] or http://www.emazzanti.net Twitter: @emazzanti Facebook: Facebook.com/emazzantitechnologies.
This webinar will demonstrate how to use cyclodextrins in parenteral applications, and how to address various formulation hurdles while highlighting their unique functionality that can propel research and development (R&D) efforts in a new direction.
Join this webinar to gain insights into cyclodextrins in parenteral drugs and the mechanisms of drug-cyclodextrin complex formation.
Join experts from Ashland, Firas El-Saleh, PhD, Principal Scientist, Pharmaceuticals, Life Sciences; and Cory Mahnen, Technology Team Leader, Parenterals, Life Sciences, for the live webinar on Wednesday, October 18, 2023, at 10am EDT (4pm CEST/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
In this free webinar, attendees will learn about some of the fundamental principles of covalent drug discovery and hear an analysis of patent activity in this competitive space between 2020-2023.
TORONTO, Oct. 5, 2023 /PRNewswire/ — The discovery of targeted covalent modulators has attracted considerable interest over the past years, driven in part by a better understanding of target engagement and pharmacodynamics, combined with innovations in the chemistry of electrophilic moieties. In this webinar, Philip Carpino, Executive Director at X-Chem, will:
Discuss the basic principles of covalent drug discovery
Provide examples of targeted covalent modulators that have been recently approved by the FDA
Summarize the diversity of warheads (or covalent reactive groups, CRGs)
Review the patent activity in this competitive space over the past few years
In addition, he will discuss several case studies and show how X-Chem can help scientists rapidly advance challenging covalent inhibitor projects using this exciting and innovative drug discovery modality.
Join this webinar to get insights into covalent drug discovery and targeted covalent modulators that have been approved by the FDA.
Join Phil Carpino for the live webinar on Tuesday, October 17, 2023, at 2 pm EDT (11am PDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
But what does community engagement really mean and what are its practical implications?
In this webinar, the featured speakers will delve into the realities of community engagement, exploring its challenges and benefits. They will also provide you with effective strategies and showcase how community engagement can successfully engage potential participants and communities, raising awareness about clinical research options.
Join this engaging discussion led by the featured speakers from EmVenio Research, as they share insights on how customized and scalable solutions can advance community engagement.
Join experts from EmVenio Research, Mark McKenzie, MD, Chief Medical Officer; Niambi Blodgett, Director, Global Patient Engagement; and Katelynn Spingola, Associate Director, Community Research Sites, for the live webinar on Wednesday, October 18, 2023, at 12pm EDT (9am PDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
RIYADH, Arabia Saudí, 5 de octubre de 2023 /PRNewswire/ — La 7ª Edición de la Future Investment Initiative (FII), programada para tener lugar del 24 al 26 de octubre de 2023 en Riad, convocará una reunión excepcional de líderes mundiales, titanes de la industria, financieros, innovadores…
“I developed TheWisdomToothDoc™ Technique in 2017 so that patients can have their wisdom teeth removed without opioids while experiencing as little pain, stress and recovery time possible,” states Dr. Babiuk. “Alone, I can only make a small difference in my local community, but if my fellow dentists and oral surgeons join forces across the country, we can help stop America’s opioid crisis from growing. I look forward to discussing this during my presentation.”
Dr. Babiuk is scheduled to be the fourth speaker on Friday, October 13, 2023, at the Action To Win Business Growth Summit in Chicago, Illinois. To learn more, visit https://actiontowin.com/bgs-oct-23.
Author of “What Every Parent of an Adolescent Needs to Know About Opioids,” one of the country’s best oral and maxillofacial surgeons and a Cook County Hospital instructor with over 25 years of expertise in private practice and anesthesia, Dr. Babiuk has removed over 234,737 teeth and counting. His offices in Joliet and Ottawa, Illinois use the safest techniques available based on a patient’s health history, state-of-art 3D scans, anatomy, and a pre-anesthetic evaluation, and offer immediate access to an onsite pharmacy and the appropriate follow-up care.
About The Centre for Oral Surgery/TheWisdomToothDoc™
The Centre for Oral Surgery/TheWisdomToothDoc offers patients alternative treatments without opioids and was founded by Dr. James Babiuk in 1998. One of the country’s best oral and maxillofacial surgeons and an instructor at Cook County Hospital, Dr. Babiuk has over 25 years of experience in private practice and over 29 years of experience in anesthesia. He has extracted over 234,737 teeth and created TheWisdomToothDoc™ Technique so that patients can experience less pain, prevent future problems and have better results without the use of opioid drugs. With locations at 3209 Fiday Rd, Joliet, IL 60431 and 1404 Aquarius Circle, Suite A, Ottawa IL 61350, patients can make an appointment by calling (815) 254-1560, texting (815) 473-3560 or visiting https://wisdomteethjoliet.com.
“At AmeriCare, our fundamental belief is that every one of our patients should have an equal opportunity to access the highest quality healthcare, regardless of their race, ethnicity, disability, sexual orientation, gender identity, geographic location, preferred language, or any other factors that may affect their access to care and health outcomes. Health equity, for us, signifies ensuring that every one of our patients has a fair and just chance to achieve their optimum level of health and well-being,” said Greg Jamian, AmeriCare Medical Inc. President and CEO.
With accounts of disparities within the healthcare sector, Jamian recognizes the urgency to address these concerns head-on within the network of companies of AmeriCare.
Jamian, a Board Member of the School of Nursing at Oakland University, met with Dr. Christopher Coleman, Ph.D., the Dean of Oakland University’s Nursing School, who is actively involved in the Big Ten Schools’ Diversity Initiative and has conducted extensive research on health disparities. This resulted in helping Jamian establish a research-informed health equity initiative that complies with the standards recognized by most of academia.
According to the National Conference of State Legislatures, individuals from marginalized communities are exposed disproportionately to conditions and environments that negatively affect health risks and outcomes and lead to higher rates of health disparities.
AmeriCare Medical Inc. aims to set a precedent within the home healthcare industry, encouraging others to prioritize diversity, equity, and inclusion as essential components of quality patient care.
“For he who has health has hope, and he who has hope has everything,” said Jamian.
About AmeriCare Medical, Inc. For more than four decades AmeriCare Medical, Inc. has provided integrated healthcare services to hospitals, assisted care facilities, and private homes throughout Michigan. AmeriCare Medical, Inc. is accredited by the Community Health Accreditation Program (CHAP) for high standards of excellence in medical staffing, private duty nursing, durable medical equipment, and specialized pharmacy services. AmeriCare Medical, Inc. is the parent company of AmeriStaff Nursing Services, Sun Medical Equipment Company, Rx iV Infusion Pharmacy, and QCN Home Health Care making it a one-stop resource for patients and their home care needs.
